Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BIO-PATH HOLDINGS, INC.BPTH · Entity 9692 | Director · President, CEO & CFO | July 30, 2024 | August 01, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BIO-PATH HOLDINGS, INC.
Report date July 30, 2024 · Filed August 01, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.55 · Expires 2024-07-30 | Direct | 25,000 |
Reported balance
After 2024-07-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-07-30 · Grant · Acquired 25,000 · Balance 25,000 F1: This option vests over a four-year period, with one-fourth (1/4) of the 25,000 shares vesting on the first anniversary of July 30, 2024, and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 25,000 shares, based on continuing service to Bio-Path Holdings, Inc. |
Filing footnotes · ownership attribution and instrument terms
F1: This option vests over a four-year period, with one-fourth (1/4) of the 25,000 shares vesting on the first anniversary of July 30, 2024, and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 25,000 shares, based on continuing service to Bio-Path Holdings, Inc.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 30, 2024 Filed Aug 1, 2024 21:56 UTC | BIO-PATH HOLDINGS, INC. BPTH · Entity 9692 | GrantCommon Stock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.55 | $0.00 |
DisclosureSEC source: 0001446472-24-000004 · primary_doc.xml · derivative · entry 1 Nielsen Peter Henry · CIK 0001444954 · Director · President, CEO & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2024-07-30 F1 · derivative.exercise_date: This option vests over a four-year period, with one-fourth (1/4) of the 25,000 shares vesting on the first anniversary of July 30, 2024, and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 25,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| May 02, 2023 Filed May 4, 2023 21:20 UTC | BIO-PATH HOLDINGS, INC. BPTH · Entity 9692 | GrantCommon Stock Option (right to buy) · Derivative | 105,000 | $0.00 Strike: $1.39 | $0.00 |
DisclosureSEC source: 0001446472-23-000010 · primary_doc.xml · derivative · entry 1 Nielsen Peter Henry · CIK 0001444954 · Director · President, CEO & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 105,000 shares Expires 2033-05-02 F1 · derivative.exercise_date: This option vests over a four-year period, with one-fourth (1/4) of the 105,000 shares vesting on the first anniversary of May 2, 2023, and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 105,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| March 23, 2022 Filed Mar 25, 2022 20:56 UTC | BIO-PATH HOLDINGS, INC. BPTH · Entity 9692 | GrantCommon Stock Option (right to buy) · Derivative | 90,000 | $0.00 Strike: $3.61 | $0.00 |
DisclosureSEC source: 0001444954-22-000001 · primary_doc.xml · derivative · entry 1 Nielsen Peter Henry · CIK 0001444954 · Director · President, CEO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2032-03-23 F1 · derivative.exercise_date: This option vests over a four-year period, with one-fourth (1/4) of the 90,000 shares vesting on the first anniversary of March 23, 2022, and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 90,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| March 31, 2021 Filed Mar 31, 2021 23:33 UTC | BIO-PATH HOLDINGS, INC. BPTH · Entity 9692 | GrantCommon Stock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $7.02 | $0.00 |
DisclosureSEC source: 0001444954-21-000001 · primary_doc.xml · derivative · entry 1 Nielsen Peter Henry · CIK 0001444954 · Director · President, CEO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2031-03-31 F1 · derivative.exercise_date: This option vests over a four-year period, with one-fourth (1/4) of the 100,000 shares vesting on the first anniversary of March 31, 2021, and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 100,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 22:28 UTC | BIO-PATH HOLDINGS, INC. BPTH · Entity 9692 | GrantCommon Stock Option (right to buy) · Derivative | 85,000 | $0.00 Strike: $5.21 | $0.00 |
DisclosureSEC source: 0001444954-20-000005 · primary_doc.xml · derivative · entry 1 Nielsen Peter Henry · CIK 0001444954 · Director · President, CEO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 85,000 shares Expires 2030-06-16 F1 · derivative.exercise_date: This option vests over a four-year period, with one-fourth (1/4) of the 85,000 shares vesting on the first anniversary of June 16, 2020, and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 85,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| March 18, 2020 Filed Mar 20, 2020 21:24 UTC | BIO-PATH HOLDINGS, INC. BPTH · Entity 9692 | GrantCommon Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $3.25 | $0.00 |
DisclosureSEC source: 0001444954-20-000001 · primary_doc.xml · derivative · entry 1 Nielsen Peter Henry · CIK 0001444954 · Director · President, CEO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2030-03-18 F1 · derivative.exercise_date: This option vests over a four-year period, with one-fourth (1/4) of the 15,000 shares vesting on the first anniversary of March 18, 2020, and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 15,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| March 28, 2019 Filed Apr 2, 2019 00:28 UTC | BIO-PATH HOLDINGS, INC. BPTH · Entity 9692 | GrantCommon Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $18.40 | $0.00 |
DisclosureSEC source: 0001007382-19-000003 · primary_doc.xml · derivative · entry 1 Nielsen Peter Henry · CIK 0001444954 · Director · President, CEO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2029-03-28 F1 · derivative.exercise_date: This option vests over a four-year period, with one-fourth (1/4) of the 15,000 shares vesting on the first anniversary of March 28, 2019, and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 15,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
| April 11, 2018 Filed Apr 13, 2018 21:01 UTC | BIO-PATH HOLDINGS, INC. BPTH · Entity 9692 | GrantCommon Stock Option (right to buy) · Derivative | 130,000 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0001444954-18-000001 · primary_doc.xml · derivative · entry 1 Nielsen Peter Henry · CIK 0001444954 · Director · President, CEO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,000 Underlying: Common Stock · 130,000 shares Expires 2028-04-11 F1 · derivative.exercise_date: This option vests over a four-year period, with one-fourth (1/4) of the 130,000 shares vesting on the first anniversary of April 11, 2018 and the remaining shares vesting thereafter in equal monthly increments equal to one-forty-eighth (1/48) of the 130,000 shares, based on continuing service to Bio-Path Holdings, Inc. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.